Kwality Pharma

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	166.29	137.49	98.32	74.17	52.38
Other Income	0.61	0.8	1.21	0.36	0.42
Stock Adjustments	-5.25	2.7	0.96	1.32	-0.88
Total Income	161.65	140.99	100.49	75.85	51.92
EXPENDITURE :
Raw Materials	114.19	104	72.19	57.48	37.6
Excise Duty	0	0	0	0	0
Power and Fuel Cost	3.71	2.76	2.81	2.31	1.8
Other Manufacturing Expenses	5.53	5.24	1.27	2.71	2.22
Employee Cost	7.74	4.89	3.6	2.16	1.6
Selling and Administration Expenses	13.71	11.07	8.91	5.35	4.66
Miscellaneous Expenses	0.44	0.56	1.6	0.46	0.35
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	16.32	12.48	10.11	5.39	3.69
Interest and Financial Charges	2.29	2.21	1.95	1.22	1.04
Profit before Depreciation and Tax	14.03	10.27	8.16	4.17	2.65
Depreciation	3.12	2.98	2.51	1.69	1.3
Minority Interest before PAT	0	0	0	0	0
Profit Before Tax	10.91	7.29	5.65	2.47	1.35
Tax	3.35	2.87	2.37	1.19	0.55
Profit After Tax	7.56	4.42	3.28	1.28	0.8
Minority Interest after PAT	0	-0.12	-0.09	-0.27	-0.11
Profit/Loss of Associate Company	0	0	0	0	0
Profit after Minority Interest and P/L of Assoc. Co.	7.55	4.55	3.36	1.55	0.92
Adjustment below Net Profit	0	-5.57	0.03	-1.06	-0.07
P and L Balance brought forward	10.02	11.05	8.03	7.53	6.68
Appropriations	0	0	0.37	0	0
P and L Bal. carried down	17.57	10.02	11.05	8.03	7.53
Equity Dividend	0	0	0.31	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0.06	0	0
Equity Dividend (%)	0	0	6	0	0
Earning Per Share (Rs.)	7.28	4.38	6.48	3.1	2.08
Book Value	35.18	27.9	47.77	41.84	43.6
Extraordinary Items	0	0.01	0	-0.19	0.02

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

166.29

137.49

98.32

74.17

52.38

Other Income

0.61

0.8

1.21

0.36

0.42

Stock Adjustments

-5.25

2.7

0.96

1.32

-0.88

Total Income

161.65

140.99

100.49

75.85

51.92

EXPENDITURE :

Raw Materials

114.19

104

72.19

57.48

37.6

Excise Duty

Power and Fuel Cost

3.71

2.76

2.81

2.31

1.8

Other Manufacturing Expenses

5.53

5.24

1.27

2.71

2.22

Employee Cost

7.74

4.89

3.6

2.16

1.6

Selling and Administration Expenses

13.71

11.07

8.91

5.35

4.66

Miscellaneous Expenses

0.44

0.56

1.6

0.46

0.35

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

16.32

12.48

10.11

5.39

3.69

Interest and Financial Charges

2.29

2.21

1.95

1.22

1.04

Profit before Depreciation and Tax

14.03

10.27

8.16

4.17

2.65

Depreciation

3.12

2.98

2.51

1.69

1.3

Minority Interest before PAT

Profit Before Tax

10.91

7.29

5.65

2.47

1.35

Tax

3.35

2.87

2.37

1.19

0.55

Profit After Tax

7.56

4.42

3.28

1.28

0.8

Minority Interest after PAT

-0.12

-0.09

-0.27

-0.11

Profit/Loss of Associate Company

Profit after Minority Interest and P/L of Assoc. Co.

7.55

4.55

3.36

1.55

0.92

Adjustment below Net Profit

-5.57

0.03

-1.06

-0.07

P and L Balance brought forward

10.02

11.05

8.03

7.53

6.68

Appropriations

0.37

P and L Bal. carried down

17.57

10.02

11.05

8.03

7.53

Equity Dividend

0.31

Preference Dividend

Corporate Dividend Tax

0.06

Equity Dividend (%)

Earning Per Share (Rs.)

7.28

4.38

6.48

3.1

2.08

Book Value

35.18

27.9

47.77

41.84

43.6

Extraordinary Items

0.01

-0.19

0.02

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	10.38	10.38	5.19	5.01	4.41
Reserves and Surplus	26.92	19.37	20.4	16.75	14.81
Total Shareholders Funds	37.3	29.75	25.59	21.76	19.22
Secured Loans	26.32	25.04	17.89	12.17	6.93
Unsecured Loans	2.42	1.41	1.17	0.72	0.93
Total Debt	28.74	26.45	19.06	12.89	7.86
Minority Interest	-0.98	-0.99	-0.5	-0.41	-0.14
Total Liabilities	65.06	55.21	44.15	34.24	26.94
APPLICATION OF FUNDS :
Gross Block	47.64	35.82	29.57	22.78	22.69
Less: Accum. Depreciation	18.56	15.44	12.56	10.06	9.95
Net Block	29.08	20.38	17.01	12.72	12.74
Capital Work in Progress	0	0	0	0	0
Investments	4.82	5.34	3.65	1.94	1
Current Assets, Loans and Advances
Inventories	11.25	15.03	13.85	10.35	6.46
Sundry Debtors	38.43	37.03	22.61	18.03	9.05
Cash and Bank Balance	1.4	1.61	2.99	1.35	1.03
Loans and Advances	20.33	16.8	10.63	6.63	6.98
Less: Current Liab. and Prov.
Current Liabilities	36.59	38.04	23.99	15.59	9.85
Provisions	3.3	2.6	2.3	1.28	0.58
Net Current Assets	31.52	29.83	23.79	19.49	13.09
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	65.42	55.55	44.45	34.15	26.83
Contingent Liabilities	0	0	0	0	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

10.38

5.19

5.01

4.41

Reserves and Surplus

26.92

19.37

20.4

16.75

14.81

Total Shareholders Funds

37.3

29.75

25.59

21.76

19.22

Secured Loans

26.32

25.04

17.89

12.17

6.93

Unsecured Loans

2.42

1.41

1.17

0.72

0.93

Total Debt

28.74

26.45

19.06

12.89

7.86

Minority Interest

-0.98

-0.99

-0.5

-0.41

-0.14

Total Liabilities

65.06

55.21

44.15

34.24

26.94

APPLICATION OF FUNDS :

Gross Block

47.64

35.82

29.57

22.78

22.69

Less: Accum. Depreciation

18.56

15.44

12.56

10.06

9.95

Net Block

29.08

20.38

17.01

12.72

12.74

Capital Work in Progress

Investments

4.82

5.34

3.65

1.94

Current Assets, Loans and Advances

Inventories

11.25

15.03

13.85

10.35

6.46

Sundry Debtors

38.43

37.03

22.61

18.03

9.05

Cash and Bank Balance

1.4

1.61

2.99

1.35

1.03

Loans and Advances

20.33

16.8

10.63

6.63

6.98

Less: Current Liab. and Prov.

Current Liabilities

36.59

38.04

23.99

15.59

9.85

Provisions

3.3

2.6

2.3

1.28

0.58

Net Current Assets

31.52

29.83

23.79

19.49

13.09

Miscellaneous Expenses not w/o

Total Assets

65.42

55.55

44.45

34.15

26.83

Contingent Liabilities

Kwality Pharma

Enjoy Lifetime Free Delivery Trade